Literature DB >> 11804681

Lung toxicity following chest irradiation in patients with lung cancer.

Raymond P Abratt1, Graeme W Morgan.   

Abstract

Classical radiation pneumonitis has been described after single dose whole lung irradiation in experimental animals where above a threshold dose of irradiation, there is a sigmoid dose response curve with increasing morbidity and mortality. After clinical fractionated irradiation, however, acute radiation pneumonitis consisting of cough shortness of breath and patchy radiological changes, occurs in <10% of patients, has dyspnoea out of proportion to the volume of lung irradiated and usually resolves completely without long-term effects. There is increasing evidence that this represents a bilateral lymphocytic alveolitis or hypersensitivity pneumonitis and has been termed sporadic pneumonitis. Late radiation toxicity results in pulmonary fibrosis. This is a consequence of repair, which is initiated by tissue injury within the radiation portal. It follows release of chemotactic factors for fibroblasts including transforming growth factor-beta, fibronectin and platelet derived growth factor. Radiation fibrosis is the clinically more significant syndrome for patients. It may result in progressive dyspnoea and mortality in patients. The most predictable change in laboratory lung function tests is a decrease in transfer factor due to damage at the capillary-alveolar level. It also results in decreased lung compliance, which will affect the total lung capacity and the forced vital capacity. The forced expiratory volume in 1 s is less affected, although this seems to depend on the volume of lung irradiated. There is also a decrease in perfusion in the irradiated lung. Radiation fibrosis seems to depend, amongst other factors, on the volume of lung, which is irradiated above a threshold of 20-30 Gy. The morbidity of radiation fibrosis may therefore be minimized by the use of dose volume histogram to minimize the volume of normal lung irradiated in patients at high risk, e.g., patients with who present with poor lung function. The importance of the baseline perfusion in the irradiated areas continues to be studied.

Entities:  

Mesh:

Year:  2002        PMID: 11804681     DOI: 10.1016/s0169-5002(01)00334-8

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  31 in total

1.  Modeling of respiratory system dysfunction among nuclear workers: a preliminary study.

Authors:  Z D Belyaeva; S V Osovets; B R Scott; G V Zhuntova; E S Grigoryeva
Journal:  Dose Response       Date:  2008-01-17       Impact factor: 2.658

2.  Protective effect of ulinastatin in patients with non-small cell lung cancer after radiation therapy: a randomized, placebo-controlled study.

Authors:  Pengtao Bao; Weiguo Zhao; Yun Li; Yu Liu; Yi Zhou; Changting Liu
Journal:  Med Oncol       Date:  2014-12-12       Impact factor: 3.064

3.  Incorporation of pre-therapy 18 F-FDG uptake data with CT texture features into a radiomics model for radiation pneumonitis diagnosis.

Authors:  Gregory J Anthony; Alexandra Cunliffe; Richard Castillo; Ngoc Pham; Thomas Guerrero; Samuel G Armato; Hania A Al-Hallaq
Journal:  Med Phys       Date:  2017-05-22       Impact factor: 4.071

4.  Radioprotective effect of diethylcarbamazine on radiation-induced acute lung injury and oxidative stress in mice.

Authors:  Soghra Farzipour; Fereshteh Talebpour Amiri; Ehsan Mihandoust; Fatemeh Shaki; Zohreh Noaparast; Arash Ghasemi; Seyed Jalal Hosseinimehr
Journal:  J Bioenerg Biomembr       Date:  2019-12-18       Impact factor: 2.945

5.  Proteomic analysis of radiation-induced changes in rat lung: Modulation by the superoxide dismutase mimetic MnTE-2-PyP(5+).

Authors:  Vasily A Yakovlev; Christopher S Rabender; Heidi Sankala; Ben Gauter-Fleckenstein; Katharina Fleckenstein; Ines Batinic-Haberle; Isabel Jackson; Zeljko Vujaskovic; Mitchell S Anscher; Ross B Mikkelsen; Paul R Graves
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-30       Impact factor: 7.038

Review 6.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

7.  Lipopolysaccharide-binding protein is efficient in biodosimetry during radiotherapy of lung cancer.

Authors:  Justyna Chalubinska-Fendler; Wojciech Fendler; Michal Spych; Krystyna Wyka; Jolanta Luniewska-Bury; Jacek Fijuth
Journal:  Biomed Rep       Date:  2016-08-08

8.  A lot to a little or a little to a lot-which dose-volume relationship ensures the best clinical outcome in the high dose radiation therapy of thoracic tumors? A prospective approach.

Authors:  Christina Schröder; Rita Engenhart-Cabillic; Hilke Vorwerk; Michael Schmidt; Winfried Huhnt; Eyck Blank; Dietrich Sidow; André Buchali
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

Review 9.  Post-operative radiation therapy (PORT) in completely resected non-small-cell lung cancer.

Authors:  Yelena Krupitskaya; Billy W Loo
Journal:  Curr Treat Options Oncol       Date:  2009-04-22

Review 10.  The epidemiology of interstitial lung disease and its association with lung cancer.

Authors:  G Raghu; F Nyberg; G Morgan
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.